These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11747795)

  • 1. [Apropos of "Onychomycoses caused by non-dermatophytic filamentous fungi in Cádiz"].
    del Palacio A; Pazos C; Cuétara S
    Enferm Infecc Microbiol Clin; 2001; 19(7):345-7. PubMed ID: 11747795
    [No Abstract]   [Full Text] [Related]  

  • 2. [Onychomycosis caused by non dermatophyte filamentous fungus].
    del Palacio A; Pazos C; Cuétara S
    Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):439-42. PubMed ID: 11709123
    [No Abstract]   [Full Text] [Related]  

  • 3. [Onychomycoses caused by non-dermatophytic filamentous fungi in Cádiz].
    García-Martos P; Domínguez I; Marín P; Linares M; Mira J; Calap J
    Enferm Infecc Microbiol Clin; 2000; 18(7):319-24. PubMed ID: 11109723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increasing frequency of onychomycoses--is there a change in the spectrum of infectious agents?].
    Ginter G; Rieger E; Heigl K; Propst E
    Mycoses; 1996; 39 Suppl 1():118-22. PubMed ID: 8767283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer systemic antifungal drugs for the treatment of onychomycosis.
    Chiritescu MM; Chiritescu ME; Scher RK
    Clin Podiatr Med Surg; 1996 Oct; 13(4):741-58. PubMed ID: 8902341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nondermatophytic filamentous fungi infection in South America--reality or misdiagnosis?
    Schechtman RC
    Dermatol Clin; 2008 Apr; 26(2):271-83, vii. PubMed ID: 18346558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Onychomycoses due to molds].
    Chabasse D; Pihet M
    J Mycol Med; 2014 Dec; 24(4):261-8. PubMed ID: 25458362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nondermatophytes. Pathogen or distracter in onychomycosis.
    Lagana FJ
    Clin Podiatr Med Surg; 1995 Apr; 12(2):255-62. PubMed ID: 7600499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillium species causing onychomycosis.
    Ramani R; Ramani A; Shivananda PG
    J Postgrad Med; 1994; 40(2):87-8. PubMed ID: 8737561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scopulariopsis Bainier as causative agent of onychomycoses (mycological and clinical study). Part II: Clinical study.
    Fragner P; Belsan I
    Acta Univ Carol Med (Praha); 1974; 20(5-6):333-58. PubMed ID: 4283276
    [No Abstract]   [Full Text] [Related]  

  • 12. Onychomycosis.
    Ramesh V; Reddy BS; Singh R
    Int J Dermatol; 1983 Apr; 22(3):148-52. PubMed ID: 6303970
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-dermatophytic onychomycosis. An understimated entity? A study of 51 cases.
    Gianni C; Cerri A; Crosti C
    Mycoses; 2000; 43(1-2):29-33. PubMed ID: 10838843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onychomycosis--epidemiology, diagnosis and management.
    Kaur R; Kashyap B; Bhalla P
    Indian J Med Microbiol; 2008; 26(2):108-16. PubMed ID: 18445944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onychomycosis. Agents of choice.
    Hay RJ
    Dermatol Clin; 1993 Jan; 11(1):161-9. PubMed ID: 8382121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey - a prospective study.
    Hilmioğlu-Polat S; Metin DY; Inci R; Dereli T; Kilinç I; Tümbay E
    Mycopathologia; 2005 Sep; 160(2):125-8. PubMed ID: 16170607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Griseofulvin in the treatment of dermatomycoses and onychomycoses produced by dermatophytes of the Trichophyton group.
    Kubec K
    Mycopathol Mycol Appl; 1968 Jan; 34(1):90-3. PubMed ID: 4231313
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model.
    Marchetti A; Piech CT; McGhan WF; Neugut AI; Smith BT
    Clin Ther; 1996; 18(4):757-77; discussion 702. PubMed ID: 8879902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis in Tehran: mycological study of 504 patients.
    Hashemi SJ; Gerami M; Zibafar E; Daei M; Moazeni M; Nasrollahi A
    Mycoses; 2010 May; 53(3):251-5. PubMed ID: 19389065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A questionnaire study on the management of onychomycosis: a Canadian perspective.
    Gupta AK; Shear NH
    Int J Dermatol; 1998 Jun; 37(6):457-60. PubMed ID: 9646138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.